Cadherins as novel targets for anti-cancer therapy

Eur J Pharmacol. 2009 Dec 25;625(1-3):195-8. doi: 10.1016/j.ejphar.2009.05.033. Epub 2009 Oct 16.

Abstract

The cell adhesion molecules N-, VE- and OB-cadherin have been implicated as regulators of tumor growth and metastasis. We discuss evidence that N- and VE-cadherin play a key role in promoting blood vessel formation and stability, processes which are essential for tumor growth. Secondly, we describe the potential involvement of N- and OB-cadherin in the metastatic process. Finally, studies concerning the effects of the N-cadherin antagonist designated ADH-1 on tumor growth are presented. Collectively, these observations suggest that antagonists of N-, VE- and OB-cadherin would be useful as anti-cancer agents.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cadherins / antagonists & inhibitors*
  • Cadherins / metabolism
  • Cell Adhesion / drug effects
  • Clinical Trials as Topic
  • Drug Delivery Systems
  • Humans
  • Neoplasm Metastasis / pathology
  • Neoplasms / drug therapy*
  • Neoplasms / physiopathology
  • Peptides, Cyclic / pharmacology

Substances

  • Antineoplastic Agents
  • Cadherins
  • N-Ac-CHAVC-NH2
  • Peptides, Cyclic